-
1
-
-
12944271053
-
Cancer statistics
-
Jemal A., Murray T., Ward E., Samuels A., Tirwari R.C., Ghafoor A. et al.: "Cancer statistics". CA Cancer J. Clin., 2005, 55, 10.
-
(2005)
CA Cancer J. Clin
, vol.55
, pp. 10
-
-
Jemal, A.1
Murray, T.2
Ward, E.3
Samuels, A.4
Tirwari, R.C.5
Ghafoor, A.6
-
2
-
-
0025009869
-
Bone metastases from gynaecologic carcinomas: Clinicopathologic study
-
Abdul-Karim F.W., Kida M., Wentz W.B. et al.: "Bone metastases from gynaecologic carcinomas: clinicopathologic study". Gynecol. Oncol., 1990, 39, 108.
-
(1990)
Gynecol. Oncol
, vol.39
, pp. 108
-
-
Abdul-Karim, F.W.1
Kida, M.2
Wentz, W.B.3
-
3
-
-
0021349366
-
Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients
-
Aalders J.G., Abeler V., Kolstad P.: "Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients". Gynecol. Oncol., 1984, 17, 85.
-
(1984)
Gynecol. Oncol
, vol.17
, pp. 85
-
-
Aalders, J.G.1
Abeler, V.2
Kolstad, P.3
-
4
-
-
0028841984
-
Surveillance for recurrent endometrial carcinoma: Development of a follow-up scheme
-
Reddoch J.M., Burke T.W., Morris M., Tornos C., Levenback C., Gershenson D.M.: "Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme". Gynecol. Oncol., 1995, 59, 221.
-
(1995)
Gynecol. Oncol
, vol.59
, pp. 221
-
-
Reddoch, J.M.1
Burke, T.W.2
Morris, M.3
Tornos, C.4
Levenback, C.5
Gershenson, D.M.6
-
5
-
-
0018743929
-
Endometrial carcinoma: Causes of death and sites of treatment failure
-
Yoonessi M., Anderson D.G., Morley G.W.: "Endometrial carcinoma: causes of death and sites of treatment failure". Cancer, 1979, 43, 1944.
-
(1979)
Cancer
, vol.43
, pp. 1944
-
-
Yoonessi, M.1
Anderson, D.G.2
Morley, G.W.3
-
6
-
-
0030065231
-
Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration
-
Morris M., Alvarez R., Kinney W., Wilson T.: "Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration". Gynecol. Oncol., 1996, 60, 288.
-
(1996)
Gynecol. Oncol
, vol.60
, pp. 288
-
-
Morris, M.1
Alvarez, R.2
Kinney, W.3
Wilson, T.4
-
7
-
-
0032878099
-
Pelvic exenteration for recurrent endometrial cancer
-
Barakat R., Goldman N., Patel D., Venkatraman E., Curtin J.: "Pelvic exenteration for recurrent endometrial cancer". Gynecol. Oncol., 1999, 75, 99.
-
(1999)
Gynecol. Oncol
, vol.75
, pp. 99
-
-
Barakat, R.1
Goldman, N.2
Patel, D.3
Venkatraman, E.4
Curtin, J.5
-
8
-
-
0034932409
-
Endometrial carcinoma and an unusual presentation of bone metastasis: A case report
-
Sahinler I., Erkal H., Akyazici E., Atkovar G., Okkan S.: "Endometrial carcinoma and an unusual presentation of bone metastasis: a case report". Gynecol. Oncol., 2001, 82, 216.
-
(2001)
Gynecol. Oncol
, vol.82
, pp. 216
-
-
Sahinler, I.1
Erkal, H.2
Akyazici, E.3
Atkovar, G.4
Okkan, S.5
-
9
-
-
34548700355
-
Hormone therapy in advanced and recurrent endometrial cancer: A systematic review
-
Decruze S.B., Green J.A.: "Hormone therapy in advanced and recurrent endometrial cancer: a systematic review". Int. J. Gynecol. Cancer, 2007, 17, 964.
-
(2007)
Int. J. Gynecol. Cancer
, vol.17
, pp. 964
-
-
Decruze, S.B.1
Green, J.A.2
-
10
-
-
2942657617
-
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group Study
-
Fleming G.F., Brunetto V.L., Cella D., Look K.Y., Reid G.C., Munkarah A.R. et al.: "Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group Study". J. Clin. Oncol., 2004, 22, 2159.
-
(2004)
J. Clin. Oncol
, vol.22
, pp. 2159
-
-
Fleming, G.F.1
Brunetto, V.L.2
Cella, D.3
Look, K.Y.4
Reid, G.C.5
Munkarah, A.R.6
-
11
-
-
0035887303
-
Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study
-
Hoskins P.J., Swenerton K.D., Pike J.A., Wong F., Lim P., Acquino-Parsons C. et al.: "Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study". J. Clin. Oncol., 2001, 19, 4048.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 4048
-
-
Hoskins, P.J.1
Swenerton, K.D.2
Pike, J.A.3
Wong, F.4
Lim, P.5
Acquino-Parsons, C.6
-
12
-
-
33750271928
-
Molecular correlates associated with a phase II study of temsirolimus (CCI779) in patients with metastatic of recurrent endometrial cancer - NCIC IND 160
-
Oza A.M., Elit L., Biagi J., Chapman M., Tsao M., Hedley D. et al: "Molecular correlates associated with a phase II study of temsirolimus (CCI779) in patients with metastatic of recurrent endometrial cancer - NCIC IND 160". J. Clin. Oncol. ASCO Annual Meeting Proceedings Part I, 2006, 24, 3003.
-
(2006)
J. Clin. Oncol. ASCO Annual Meeting Proceedings Part I
, vol.24
, pp. 3003
-
-
Oza, A.M.1
Elit, L.2
Biagi, J.3
Chapman, M.4
Tsao, M.5
Hedley, D.6
-
13
-
-
37149010753
-
Phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer
-
Colombo N., McMeekin S., Schwartz P., Kostka J., Sessa C., Gehrig P. et al.: "Phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer". J. Clin. Oncol. ASCO Annual Meeting Proceedings Part I, 2007, 25, 5516.
-
(2007)
J. Clin. Oncol. ASCO Annual Meeting Proceedings Part I
, vol.25
, pp. 5516
-
-
Colombo, N.1
McMeekin, S.2
Schwartz, P.3
Kostka, J.4
Sessa, C.5
Gehrig, P.6
|